Photocure is a pharmaceutical company based in Oslo, Norway, that develops and supplies products for the detection and management of bladder cancer. Its main offering is a diagnostic agent used during cystoscopy, a procedure in which urologists examine the bladder with a special light system to find tumours. The company serves hospitals, clinics and medical specialists who diagnose and monitor patients with the disease. Photocure also works on related technology and products for urology and cancer care.
On this site Photocure appears as a stock on the Oslo Stock Exchange (Norway), code PHO, with prices in Norwegian kroner (NOK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #221 of 294 on the Oslo Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Norway yet.
TrendWeak
20/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-18.8%
From 52-week high-38.0%
MomentumWeak
26/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-13.1%
6-month return-29.6%
12-month, skipping last month1.2%
Stability (higher is calmer)Weak
38/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)41.3%
Worst drawdown, 1 year (smaller is calmer)-39.1%
LiquidityFair
56/100
Moderate trading activity.
See the numbers →
Avg daily value traded3.61M NOK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Norway when fundamentals data for this market is added. All Norway stocks.
52-wk range 46.25 – 79.80Daily closes, split-adjusted
Signals
50-day average51.73
200-day average60.33
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.26
Technical summary
Daily
Strongly bearish
0 bullish · 4 neutral · 12 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
49.60
Bearish
EMA 10
49.57
Bearish
SMA 20
49.35
Bearish
EMA 20
49.84
Bearish
SMA 50
51.73
Bearish
EMA 50
51.46
Bearish
SMA 100
54.37
Bearish
EMA 100
54.17
Bearish
SMA 200
60.33
Bearish
EMA 200
57.06
Bearish
Oscillators (daily)
RSI (14)
42.34
Neutral
MACD (12, 26)
-0.53
Bearish
Momentum (12)
-1.01
Bearish
Stochastic %K (14)
33.33
Neutral
Williams %R (14)
-66.67
Neutral
CCI (20)
-52.23
Neutral
Pivot points (classic, last session)
S3
47.47
S2
48.03
S1
48.52
Pivot
49.08
R1
49.57
R2
50.13
R3
50.62
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in NOK. Educational only, not financial advice.
